Novartis India Limited
NOVARTIND.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$50.56B
Close$
$1178.99
34.1% downside
Current Fair Value
34.1% downsideOvervalued by 34.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $50.56 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $37.74 |
| Beta | 0.32 |
| Outstanding Shares | 24,690,797 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 51.69 |
|---|---|
| PEG | 311.06 |
| Price to Sales | 11.93 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Novartis India Limited
59 employees
CEO: Vikas Gupta Novartis India Limited, an affiliate of Novartis AG, operates as a healthcare enterprise primarily within India. The company's diverse portfolio encompasses a range of therapeutic solutions. These include bone and pain management treatme...